| 6M7I | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | GOL, J84 | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Active-Site Druggability of Carbapenemases and Broad-Spectrum Inhibitor Discovery., Torelli NJ, Akhtar A, DeFrees K, Jaishankar P, Pemberton OA, Zhang X, Johnson C, Renslo AR, Chen Y, ACS Infect Dis. 2019 Apr 15. doi: 10.1021/acsinfecdis.9b00052. PMID:30942078 | ||||||||||||||
| Data retrieval |
![]() |
| View 6M7I in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |